Get the Stockscreener App
424.53
2.42%
-10.51
After Hours:
425.00
0.47
+0.11%
Overview
News
Price History
Option Chain
Financials
Why ELV Down?
Discussions
Forecast
Stock Split
Dividend History
Elevance Health Inc stock is traded at $424.53, with a volume of 3.57M.
It is down -2.42% in the last 24 hours and down -1.41% over the past month.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$435.04
Open:
$390
24h Volume:
3.57M
Relative Volume:
2.16
Market Cap:
$99.88B
Revenue:
$176.81B
Net Income/Loss:
$5.98B
P/E Ratio:
16.58
EPS:
25.61
Net Cash Flow:
$4.55B
1W Performance:
-2.71%
1M Performance:
-1.41%
6M Performance:
-4.46%
1Y Performance:
-16.59%
1-Day Range:
$390.00
$437.99
1-Week Range:
$390.00
$443.29
52-Week Range:
$362.21
$567.26
Elevance Health Inc Stock (ELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
(800) 331-1476
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
424.53 | 99.88B | 176.81B | 5.98B | 4.55B | 25.61 |
|
UNH
Unitedhealth Group Inc
|
454.11 | 536.99B | 400.28B | 14.41B | 20.71B | 15.50 |
|
CI
Cigna Group
|
330.13 | 89.25B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
67.29 | 87.36B | 372.81B | 4.61B | 6.33B | 3.66 |
|
HUM
Humana Inc
|
264.48 | 34.38B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-17-25 | Upgrade | Argus | Hold → Buy |
| Jan-22-25 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-18-24 | Downgrade | Argus | Buy → Hold |
| Jul-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-24-24 | Initiated | Morgan Stanley | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-28-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
View All
Elevance Health Inc Stock (ELV) Latest News
Elevance Health preannounced Q1 earnings beat ‘quite positive,’ says Baird - Yahoo Finance
Will a Strong MA Business Aid Elevance Health's Q1 Earnings? - MSN
Elevance Health's Preliminary Q1 Earnings Help Ease Market Concerns, Truist Says - MarketScreener
MU Health 'out of network' for Elevance Health/Anthem patients after insurer fails to reach agreement - Read Lion
Elevance Health Expects Q1 Earnings Above Estimates, Retains Full-Year Guidance: But Retail’s Pessimistic - Investing.com India
Elevance Health (ELV) Surpasses Q1 Earnings Projections, Maintains Full-Year Outlook - GuruFocus
Elevance Maintains Profit Guidance After UnitedHealth Cut - Bloomberg
Elevance Health's Preliminary Q1 Adjusted Net Income Rises - MarketScreener
CVS, Humana and Elevance Shares Are Trading Lower Thursday: What's Going On? - Benzinga
Elevance Health projects steady Q1 results, confirms 2025 outlook - Investing.com
Elevance Health stock in focus after Q1 outlook (ELV:NYSE) - Seeking Alpha
Elevance Health Projects Q1 2025 Earnings Expectations - TipRanks
Elevance Health projects steady Q1 results, confirms 2025 outlook By Investing.com - Investing.com South Africa
Elevance maintains profit forecast after rival UnitedHealth's outlook cut - Reuters
Elevance Health (ELV) to Announce Q1 2025 Earnings on April 22 | ELV Stock News - GuruFocus
Elevance Health (ELV) to Announce Q1 2025 Financial Results on April 22 | ELV Stock News - GuruFocus
Health insurer Elevance sees first-quarter profit above estimates - marketscreener.com
Ahead of Elevance Health (ELV) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
Anthem Strikes Deal To End Mental Health Class Action - Law360
Baird Downgrades Elevance Health (BIT:1ANTM) - Nasdaq
Elevance Health (NYSE:ELV) Faces Shareholder Proposal on Diversity and Inclusion Reporting - Yahoo Finance
Morgan Stanley Adjusts Elevance Health Price Target to $428 From $405, Maintains Equal Weight Rating - MarketScreener
Elevance Health (NYSE:ELV) stock performs better than its underlying earnings growth over last five years - Yahoo Finance
Elevance Health (ELV) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
How Do Investors Really Feel About Elevance Health? - Benzinga
Implied Volatility Surging for Elevance Health (ELV) Stock Options - Yahoo Finance
Morgan Stanley Adjusts Price Target for Elevance Health (ELV) to $428 | ELV Stock News - GuruFocus
Elevance Health (ELV) Downgraded by Baird Amid Policy Uncertaint - GuruFocus
Elevance Health: A Hidden Gem Amongst Healthcare Turbulence - Seeking Alpha
5 of the Safest Stocks Billionaire Money Managers Bought Ahead of Wall Street's Historic Volatility - The Motley Fool
Truist Increases Price Target for Elevance Health (ELV) Ahead of Q1 Results | ELV Stock News - GuruFocus
Elevance Health, Inc. (ELV): Among the Best Medical Stocks to Buy According to Billionaires - Insider Monkey
Truist Securities Raises Price Target on Elevance Health to $510 From $480, Keeps Buy Rating - MarketScreener
Elevance Health, Inc.'s (NYSE:ELV) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo
Elevance Beats Teacher's Bias Suit Over Weight Loss Drugs - Law360
Guggenheim Initiates Coverage of Elevance Health (BMV:ELV) with Buy Recommendation - Nasdaq
Guggenheim Initiates Coverage of Elevance Health (WBAG:ELV) with Buy Recommendation - Nasdaq
Guggenheim Initiates Coverage of Elevance Health (BIT:1ANTM) with Buy Recommendation - Nasdaq
Elevance Beats Bias Claim Over Plan's Weight Loss Drug Exclusion - Bloomberg Law News
Elevance Health (ELV) is Rebounding From Sell Off - Insider Monkey
Guggenheim Initiates Coverage of Elevance Health (ELV) with Buy Recommendation - Nasdaq
Jared Moskowitz trades in Broadcom and Elevance Health stocks, buys into NVIDIA, SPDR Gold Trust, and TJX Companies - Investing.com India
5 Analysts Assess Elevance Health: What You Need To Know - Benzinga
Elevance Health Women's Fort Myers Tip-Off comes to Scripps Sports, ION in multiyear agreement - Yahoo Finance
Guggenheim Initiates Elevance Health at Buy With $518 Price Target - marketscreener.com
Guggenheim sets Elevance stock Buy rating with $518 target By Investing.com - Investing.com India
Guggenheim sets Elevance stock Buy rating with $518 target - Investing.com
US health insurers jump as 2026 Medicare payment rates exceed expectations - Reuters
Health Insurers Surge After Medicare Agency Increases Payment Rates - Benzinga
US releases final Medicare payment rates for 2026 - MarketScreener
Elevance Health (NYSE:ELV) Seems To Use Debt Quite Sensibly - Yahoo Finance
Elevance Health Inc Stock (ELV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
1.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):